DENTSPLY International (XRAY) Lower as UBS Downgrades to Sell

Article Stock Quotes (1) Comments (0)

DENTSPLY International (NASDAQ: XRAY) is lower on the day after UBS downgraded the stock from Neutral to Sell with a price target of $35.00 (from $39.00).

"Based on recent datapoints from Nobel Biocare (global dental implant mfr), and Align Technologies (ALGN; specialty dental mfr), it seems that trends in dental markets have softened notably in 3Q12 and into 4Q12 in the U.S market in particular, but also with notions of softness in Japan and Europe as well."

For an analyst ratings summary and ratings history on DENTSPLY International click here. For more ratings news on DENTSPLY International click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
• Microsoft (MSFT) Rally Not Over Says UBS; Raises PT to $40
• Jefferies Raises Numbers on hhgregg (HGG), But Remains on Sidelines

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

UBS

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?